Stocks and Investing Stocks and Investing
Tue, February 11, 2020
[ 12:00 AM ] - WOPRAI
David Coleman Downgraded (SPH) to Strong Sell on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Paul Coster Downgraded (TPIC) to Hold and Held Target at $24 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Steve Moss Reiterated (BPRN) at Hold with Increased Target to $33 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Tuna Amobi Maintained (TGNA) at Strong Buy with Increased Target to $19 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Joseph Giordano Maintained (TDY) at Buy with Increased Target to $415 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Ryan MacDonald Maintained (CHGG) at Strong Buy with Increased Target to $53 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Josh Baer Maintained (CHGG) at Buy with Increased Target to $49 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Alison Jacobowitz Maintained (ALL) at Strong Buy with Increased Target to $134 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Christopher Marai Maintained (ALNY) at Sell with Increased Target to $75 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Mitch Steves Maintained (AMD) at Buy with Increased Target to $63 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Keenan Omar Initiated (BCS) at Hold on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Trey Grooms Reiterated (BECN) at Buy with Increased Target to $38 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
David Risinger Maintained (BHC) at Buy with Decreased Target to $32 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (AAP) at Hold with Decreased Target to $140 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
John Murphy Upgraded (ABG) to Strong Buy on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Arren Cyganovich Initiated (VEL) at Strong Buy on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Steven Delaney Initiated (VEL) at Buy and Held Target at $22 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Donald Fandetti Initiated (VEL) at Buy and Held Target at $19 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Stephen Laws Initiated (VEL) at Buy and Held Target at $17 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
David Coleman Upgraded (UTI) to Strong Buy and Held Target at $12 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Arun Sundaram Downgraded (USFD) to Strong Buy and Decreased Target to $45 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Madhu Kumar Initiated (ARCT) at Buy and Held Target at $24 on, Feb 11th, 2020
[ 12:00 AM ] - WOPRAI
Garrett Nelson Reiterated (AN) at Strong Buy with Decreased Target to $60 on, Feb 11th, 2020
Mon, February 10, 2020
[ 12:00 AM ] - WOPRAI
Naved Khan Maintained (CARG) at Strong Buy with Increased Target to $55 on, Feb 10th, 2020
[ 12:00 AM ] - WOPRAI
Chris Allen Downgraded (CBOE) to Hold and Held Target at $127 on, Feb 10th, 2020
[ 12:00 AM ] - WOPRAI
Ben Herbert Maintained (CBOE) at Hold with Increased Target to $122 on, Feb 10th, 2020
[ 12:00 AM ] - WOPRAI
Edward Nash Initiated (AKRO) at Strong Buy and Held Target at $36 on, Feb 10th, 2020
[ 12:00 AM ] - WOPRAI
Michael Zaremski Maintained (AJG) at Buy with Increased Target to $115 on, Feb 10th, 2020
[ 12:00 AM ] - WOPRAI
Alethia Young Upgraded (ADVM) to Buy and Increased Target to $210 on, Feb 10th, 2020
[ 12:00 AM ] - WOPRAI
Gbola Amusa Upgraded (ADVM) to Strong Buy and Increased Target to $200 on, Feb 10th, 2020

Gbola Amusa Upgraded (ADVM) to Strong Buy and Increased Target to $200 on, Feb 10th, 2020


Published on 2024-10-26 21:42:44 - WOPRAI, Gbola Amusa
  Print publication without navigation


Gbola Amusa of Chardan Capital, Upgraded "Adverum Biotechnologies, Inc." (ADVM) to Strong Buy and Increased Target from $100 to $200 on, Feb 10th, 2020.

Gbola has made no other calls on ADVM in the last 4 months.



There is 1 other peer that has a rating on ADVM. Out of the 1 peers that are also analyzing ADVM, 0 agree with Gbola's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gbola

  • Tyler Van Buren of "Piper Sandler" Reiterated at Buy with Increased Target to $200 on, Monday, January 13th, 2020
Contributing Sources